Goldman Sachs reiterates a Buy rating on Eli Lilly, pointing to progress in obesity drug development
The bank said Eli Lilly’s pipeline momentum and recent regulatory and coverage updates around obesity treatment are sustaining investor interest.
Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
The bank said Eli Lilly’s pipeline momentum and recent regulatory and coverage updates around obesity treatment are sustaining investor interest.
THE APEX TIMES
A recent market commentary says the AI buildout is not just a NVIDIA story, pointing instead to Micron and Dell as beneficiaries of surging demand for AI memory and related data-center spending.
A Yahoo Finance report frames a new scoreboard for Elon Musk’s businesses, arguing that once SpaceX shares begin trading, Musk’s ranking of whose value matters most could shift from Tesla to SpaceX even as investors weigh uncertainty around both companies’ futures.
The healthcare provider says it will use Salesforce’s Agentforce Health to improve the experience of members calling customer service and to assist roughly 1.5 million healthcare providers connected to its network.
The award, reported by Yahoo Finance, is aimed at upgrading workforce and HR capabilities across the U.S. federal government at a scale that affects roughly one in every several federal workers.
Marvell said it is tapping Dan Durn, currently an executive at Adobe, for the role of chief financial officer as the company continues positioning itself for growth tied to artificial intelligence demand.
A sharp rise in MediaTek’s shares highlighted investor optimism that Google’s expanding artificial-intelligence compute efforts could eventually benefit suppliers beyond traditional smartphone chips.
The collaboration pairs Meta with TV host Mike Rowe to expand access to paid, skills-based training for trades roles, a push that arrives as demand rises around new artificial-intelligence data center builds.
The chipmaker has hired an experienced government affairs figure for a Washington position, underscoring how regulatory and geopolitical pressure are increasingly shaping the business of AI chips.